CRISPR is a technology being used on a frequent basis in the world of the genome in order to bring about either enhancement or decline in a specific variety of genome for further improvement in the concerned species. At the moment, the genome editor CRISPR is being put to use in a variety of crops such as wheat and corn owing to their tough cell structure that makes editing in their genome tougher than expected. One of the top agricultural companies has made it possible by making use of pollen from a genetically modified plant (GMO) plant to transfer CRISPR components into other plant’s cells. According to the current study, this new technique can help create more versatile crop varieties.
According to Plant Biologist Daniel Voytas from the University of Minnesota, the edited varieties of corn have been able to provide more kernels. The idea of delivering gene-editing components followed by efficiently convalesce gene-edited plants is an amazing concept in today’s era. The enzymatic scissors called Cas9 transfer and edit specific targeted locations in the genome. The use of bacterium sources and gene gun method to transfer CRISPR genes in many plant species are some of the popular and efficient techniques being used till date.
The team led Timothy Kelliher and Qiudeng Que of Syngenta worked on developing haploid plants using the pollen to bring about the haploid induction so as to increase the breeding activity and yield of the plants. Syngenta is focusing on enhancing the breed efficiency of the corn plants using the current study. The combination of haploid induction and genome editing is definitely bliss for the humans who have huge pollution to feed in the coming years. This key innovation is something the human evolution has long been waiting to produce tonnes of food for the millions across the globe. The U.S. regulation is working on getting regulatory approval for the sale of such genetically modified crops. Researchers from the University of Edinburgh’s Roslin Institute along with Roslin Technologies have genetically tailored chickens to create human proteins in their eggs that will offer a pocket-friendly method for developing particular types of drugs.